2 High-Yield Dividend ETFs That Could Deliver Steady Income for Decades
The Schwab U.S. Dividend Equity ETF and Fidelity High Dividend Yield ETF both offer fat payouts.
The Schwab ETF has increased its dividend by more than 160% over the past decade.
Fidelity's ETF has outperformed all three major U.S. indexes over the past five years.
10 stocks we like better than Schwab U.S. Dividend Equity ETF ›
With the stock market being notorious for its volatility and uncertainty, it's nice to have a reliable income stream you can count on. That's where dividends come into the picture. Dividends provide stable income, regardless of stock price movements.
Dividend stocks aren't immune to volatility or uncertainty, but the guaranteed income offsets some of the risk of stock investing. For an added layer of security, consider investing in dividend-focused exchange-traded funds (ETFs). Many offer yields as high as single stocks and are more stable because it's many companies doing the lifting.
If you're looking for steady income for years to come, the Schwab U.S. Dividend Equity ETF (NYSEMKT: SCHD) and Fidelity High Dividend Yield ETF (NYSEMKT: FDVV) are great options. They both offer dividend yields more than double the average and are led by companies that make me confident it can be a go-to for quite some time.
1. Schwab U.S. Dividend Equity ETF
This ETF tracks the Dow Jones U.S. Dividend Index, which focuses on companies with a history of consistent dividend payments and strong financial performance. It's one of the most popular dividend ETFs on the stock market and is known for holding blue chip dividend stocks like Coca-Cola, Altria, and AbbVie -- all of which are Dividend Kings.
The criteria to be included in Schwab ETF mean it's filled with well-established companies that have stood the test of time. That's what you want when you're investing for the long haul, because there are many instances of companies having to cut or suspend their dividend to help fix their finances during a rough patch.
Dividend payouts from ETFs fluctuate because different companies pay on different schedules, but the Schwab fund has maintained a dividend yield of at least 3.1% over the past three years. Its last four payouts were $0.2602, $0.2488, $0.2645, and $0.7545, averaging out to a yield of over 5.6% yield at its $26.90 price at the time of this writing.
Arguably more important -- especially for long-term investors -- is the rate at which Schwab U.S. Dividend Equity ETF has been able to increase its dividend. In the past 10 years, it has increased by more than 160%.
2. Fidelity High Dividend Yield ETF
Whereas the Schwab ETF emphasizes value-leaning companies, the Fidelity ETF contains a mix of companies that offer both consistent income and growth opportunities. Its top three holdings are Nvidia, Microsoft, and Apple, accounting for over 16% of the fund as of June 30. The tech sector represents over a quarter of the fund (vs. just 7% for the Schwab fund).
The Fidelity ETF's dividend yield isn't eye-popping (although above 3% is impressive for a broad ETF), but it works out to be a true 2-for-1 when you consider its stock price appreciation. Over the past five years, the Fidelity ETF has outperformed all three of the stock market's major indexes.
A high concentration of tech stocks isn't typical for a dividend ETF, as many of these companies prioritize reinvesting profits for growth rather than paying dividends. However, it works out in the Fidelity High Dividend Yield ETF's case because its top holdings are mature tech companies with a strong cash flow and the ability to do both.
You don't have to pick one ETF or the other
If you're interested in both ETFs, the good news is that they cover a good amount of ground without too much overlap. It's common for similarly themed ETFs to hold many of the same stocks, but that's not the case with these two funds. Only 19 stocks are in both ETFs out of more than 100 holdings in each fund.
Investing in both could allow you to benefit from Schwab U.S. Dividend Equity ETF's reliability and low cost, and Fidelity High Dividend Yield ETF's mix of growth and income.
Should you invest $1,000 in Schwab U.S. Dividend Equity ETF right now?
Before you buy stock in Schwab U.S. Dividend Equity ETF, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Schwab U.S. Dividend Equity ETF wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $652,133!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,056,790!*
Now, it's worth noting Stock Advisor's total average return is 1,048% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor.
See the 10 stocks »
*Stock Advisor returns as of July 21, 2025
Stefon Walters has positions in Apple, Coca-Cola, and Microsoft. The Motley Fool has positions in and recommends AbbVie, Apple, Microsoft, and Nvidia. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.
2 High-Yield Dividend ETFs That Could Deliver Steady Income for Decades was originally published by The Motley Fool

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 minutes ago
- Yahoo
Why we are seeing another meme stock moment: eToro CEO
July has brought the return of the meme stock moment, led by frenzied activity in Opendoor (OPEN), Krispy Kreme (DNUT), GoPro (GPRO), and GameStop (GME). Don't count eToro co-founder and CEO Yoni Assia as surprised. "I think generally the rise of retail investors is a huge trend," Assia told me on Yahoo Finance. "We are still at the beginning of what we believe is the largest transformation of wealth in human history from older generations to younger generations." Assia is using the summer retail investor reawakening to push eToro's business into new territory. eToro said Tuesday it would debut 24-hour, five-day-a-week trading on 100 of the most popular stocks and ETFs in the market. The company will join rival Robinhood (HOOD) in trying to convince lawmakers to make stock trading around the clock. "I think 24/7 is probably going to take longer simply because the markets themselves are usually closed over the weekend, and there's still liquidity issues," Assia explained. "I think 24/5 is happening now in 2025 and 2026, and it's gradually happening across asset classes and also happening with more and more stocks available for 24/5 trading." The company also announced spot-quoted futures. It teased the launch of US-listed equities as tokens on the ethereum blockchain. eToro priced its IPO in mid-May at $52 a share, above the planned range of $46 to $50. The company raised about $310 million in the offering. Today, the stock trades around $62.50, giving the company a market cap of $5.2 billion. It has more than 40 million registered users. Robinhood and Interactive Brokers are valued at $95 billion and $111 billion, respectively. eToro was co-founded in 2007 in Israel by Yoni and his older brother, Ronen Assia. Yoni has said the company was started in his parents' garage. Ronen sits on the management team and is an executive director. The company quickly grew from its inception as new investors entered a bull market, initially raising $1.5 million at a $5 million valuation. It launched bitcoin trading in 2013, around the time of the crypto winter that depressed digital asset Sozzi is Yahoo Finance's Executive Editor and a member of Yahoo Finance's editorial leadership team. Follow Sozzi on X @BrianSozzi, Instagram, and LinkedIn. Tips on stories? Email Sign in to access your portfolio
Yahoo
6 minutes ago
- Yahoo
Southeast Asia Casting Polyurethane Market to Surpass Valuation of US$ 308.18 Million By 2033
The Southeast Asia casting polyurethane market is defined by industrial expansion, driving demand for durable polyester-based rollers and custom elastomeric parts valued for superior load-bearing capacity and operational longevity in manufacturing, mining, and infrastructure sectors. Chicago, July 29, 2025 (GLOBE NEWSWIRE) -- The Southeast Asia casting polyurethane market was valued at US$ 158.31 million in 2024 and is expected to reach US$ 308.18 million by 2033, growing at a CAGR of 7.82% during the forecast period 2025–2033. The Southeast Asia casting polyurethane market is entering a period of unprecedented expansion, poised for significant growth throughout 2024 and 2025. This surge is not a fleeting trend but a fundamental shift, underpinned by vigorous industrialization, substantial foreign investment, and a widespread regional pivot towards high-performance, durable materials. As manufacturing capabilities across the block intensify and diversify, casting polyurethane is emerging as a critical enabling material. Download a Free Sample to Preview the Report: The heavy reliance on casting as a production method is a cornerstone of the casting polyurethane market in Southeast Asia, driven by its unparalleled cost-effectiveness and design freedom for industrial applications. This method provides a clear advantage over traditional manufacturing, particularly for custom and low-to-medium volume production. A Malaysian foundry, in its 2024 annual review, cited a 40% reduction in lead time for custom industrial parts since incorporating polyurethane casting. The process facilitates significant part consolidation and optimization; a Vietnamese agricultural machinery manufacturer, in a 2025 case study, revealed that redesigning a metal assembly into a single cast polyurethane component cut its weight by 60% and its cost by 25%. This efficiency is why specialized firms, like a Singaporean automation company, now use cast polyurethane for over 70% of their custom jigs and fixtures as of early 2025. This report provides an in-depth analysis of the key drivers, sectoral opportunities, and country-specific dynamics shaping this vibrant market, offering stakeholders meticulously researched insights to guide strategic decisions and capitalize on the burgeoning demand landscape. Key Findings in Southeast Asia Casting Polyurethane Market Market Forecast (2033) US$ 308.18 million CAGR 7.82% By Product Type Rolls (34.06%) By Prepolymer Type Polyester Based Prepolymer (43.65%) By Manufacturing Process Casting (Liquid Polyurethane) (50.38%) By Design Elastomeric (39.09%) By Application Industrial Castings (30.34%) By Distribution Channel Distributors/Wholesalers (58.46%) By Industry Automotive (26.73%) Top Drivers Rapid industrialization and manufacturing expansion are driving regional market growth. Increasing investment in infrastructure development fuels polyurethane component demand. Superior performance characteristics over traditional materials like rubber and metal. Top Trends Growing demand for high-performance polyester-based polyurethane for durable applications. Shift towards sustainable and bio-based polyurethane materials is gaining traction. Rising adoption of automation for customized industrial component production. Top Challenges High volatility in raw material prices impacts overall production costs. Intense competition from low-cost materials and fragmented local market players. Limited skilled technicians for complex and advanced polyurethane processing methods. Unprecedented Industrial Expansion Fuels Demand in the Southeast Asia Casting Polyurethane Market At the heart of this growth story is the region's dynamic economic evolution. A confluence of favorable government policies, a rapidly growing middle class, and the relocation of global supply chains is transforming Southeast Asia into a global manufacturing powerhouse. This industrial renaissance is a primary catalyst for the Southeast Asia casting polyurethane market, as industries from automotive to electronics demand materials that offer superior durability, versatility, and performance. The transition away from traditional materials towards advanced polymers like casting polyurethane is accelerating, driven by the need for efficiency, longevity, and higher quality standards in finished products. Automotive Sector Surge Creates Significant Opportunities for Casting Polyurethane Applications The regional automotive industry stands out as a principal consumer in the casting polyurethane market of the Southeast Asia, with its aggressive expansion plans directly fueling demand for cast polyurethane components like bushings, seals, and interior parts. In Thailand, the automotive hub of the region, manufacturers are projected to increase their production targets for electric vehicles by a substantial 15% in 2025, a move that requires advanced polyurethane materials for lightweighting and battery components. Vietnam's commercial vehicle production is simultaneously expected to see a 10% rise in 2024. This growth extends to the aftermarket, where Malaysia's sector is forecast to expand by 8% in 2024, increasing the need for durable cast polyurethane replacement parts. Underscoring this trend, a leading Japanese automaker has committed a $200 million investment to expand its Indonesian production facility, with a scheduled completion in 2025. Monumental Infrastructure and Construction Projects Propel Polyurethane Consumption Across the Region A massive wave of infrastructure development is sweeping across Southeast Asia, creating immense demand for construction-related polyurethane applications such as flooring, insulation, coatings, and sealants. The Philippine government has allocated an additional $5 billion for vital infrastructure projects in 2024, directly boosting the Southeast Asia casting polyurethane market. In Vietnam, the urban landscape is changing rapidly, with the construction of high-rise residential and commercial buildings expected to increase by 12% in 2025. Sustainability is also a key factor; Thailand's green building initiatives are projected to drive a 20% increase in the use of energy-efficient polyurethane insulation in 2024. Furthermore, Malaysia is strategically planning the development of three new industrial parks in 2025, which will create significant, concentrated demand for industrial-grade polyurethane flooring and sealants. Advanced Electronics Manufacturing Hubs Drive Demand for Specialized Polyurethane Formulations Southeast Asia casting polyurethane market's role in the global electronics supply chain is becoming increasingly sophisticated, fueling the need for specialized casting polyurethane for potting, encapsulation, and thermal management. Singapore continues to lead in high-value manufacturing, evidenced by a major semiconductor firm's $1 billion investment in a new fabrication plant set to be operational by 2025. Vietnam's consumer electronics production is on a sharp upward trajectory, with an anticipated growth of 15% in 2024, boosting the use of polyurethane to protect sensitive components. Concurrently, the digital economy's expansion is driving a 25% projected increase in the demand for data centers in Indonesia in 2025, a sector that requires specialized polyurethane materials for critical thermal management systems to ensure operational stability. Heavy Industries and Mining Operations Demand High-Performance Casting Polyurethane Solutions In the region's demanding heavy industrial and mining sectors, the superior abrasion and impact resistance of casting polyurethane makes it the material of choice for critical components. Indonesia's formidable mining sector, for instance, is expected to increase its output by 7% in 2024, directly driving higher demand for hard-wearing polyurethane screens, scrapers, and equipment liners that can withstand harsh operational conditions. This need for durability is also seen in maritime infrastructure. The expansion of a major port in Malaysia, a massive project valued at $500 million and due for completion in 2025, will significantly increase the requirement for robust polyurethane fenders, buoys, and wear pads, showcasing the material's critical role in large-scale industrial applications and its importance to the Southeast Asia casting polyurethane market. A Granular Country-Level Analysis of the Southeast Asia Casting Polyurethane Market A closer look at individual nations reveals distinct and compelling growth narratives. Thailand, solidifying its position as an automotive hub, aims to produce over 500,000 electric vehicles annually by 2025, while its burgeoning medical device market is projected to grow by 9% in 2024, increasing the use of biocompatible cast polyurethanes. Vietnam is a manufacturing titan, with its manufacturing PMI expected to remain strong above 52.0 throughout 2024, and its footwear export value is forecast to climb by 10% in 2025, driven by demand for polyurethane soles. Indonesia's growth is powered by its natural resources and manufacturing sectors. The country is set to increase its nickel processing capacity by 30% in 2024 and its furniture export market is expected to grow by 8% in 2025, increasing the use of polyurethane coatings and foams. In Malaysia, the oil and gas sector is planning 15 new offshore projects by the end of 2025, creating strong demand for pipeline coatings and seals. Malaysia's renewable energy sector is also expanding, aiming to add 1,200 MW of solar capacity in 2024, utilizing polyurethane in panel manufacturing. The Philippines showcases growth fueled by domestic activity; overseas worker remittances, a key driver of construction, are projected to increase by 4% in 2024, while the nation's shipbuilding and repair industry is expected to see 6% growth in 2025. This diverse country-level activity solidifies the bright prospects for the Southeast Asia casting polyurethane market. Analyzing the Crucial Raw Material and Supply Chain Dynamics for Regional Success The continued growth of the Southeast Asia casting polyurethane market is intrinsically linked to the stability and evolution of its supply chain. The availability of key raw materials, namely MDI (methylene diphenyl diisocyanate) and polyols, is a critical factor for manufacturers. In a significant development for regional supply, a new MDI production facility is expected to come online in late 2024, adding 50,000 metric tons of annual capacity and potentially easing supply constraints. From a cost perspective, industry analysts anticipate a moderate increase of 3-5% for polyol prices in the first half of 2025 due to global supply chain realignments. To support this flow of materials, regional investment in logistics and warehousing infrastructure is projected to increase by a remarkable 18% in 2024, enhancing efficiency and ensuring timely delivery across the thriving Southeast Asia market. Need a Customized Version? Request It Now: Future Outlook: Sustained Momentum for the Southeast Asia Casting Polyurethane Market The outlook for the Southeast Asia market through 2025 and beyond is exceptionally promising. The convergence of macro-economic strength targeted industrial policy, major infrastructure investment, and technological advancement creates a powerful and sustained tailwind. The 70 distinct findings presented in this analysis collectively paint a picture of a market rich with opportunity, driven by diverse and robust end-use sectors. From the electric vehicles rolling off production lines in Thailand to the new semiconductor fabs in Singapore and the expanding mines in Indonesia, casting polyurethane is the common denominator of progress and performance. Stakeholders who align their strategies with these powerful growth vectors are well-positioned to achieve remarkable success in the dynamic and rapidly expanding Southeast Asia casting polyurethane market. Southeast Asia Casting Polyurethane Market Major Players BASF SE Evonik Industries Sika AG Dow Inc. Asia Polyurethane Line Seiki Co., Ltd. Prostech Seen Joo Pte Ltd Other Prominent Players Key Segmentation: By Product Type Rolls Formwork Pads Sheets Others By Prepolymer Type Polyester Base Prepolymer Polyether Base Prepolymer Polycaprolactone Base Prepolymer Others By Resin Grade Standard Grade High-Performance Grade Specialty Grade Others By Manufacturing Process Reaction Injection Molding (RIM) Casting (Liquid Polyurethane) Extrusion Compression Molding Others By Design Rigid Flexible Foamed Elastomeric Others By Application Industrial Castings Wheels & Tires Belt & Hoses Medical Devices Footwear Components Concrete Blocks Others By Distribution Channel Direct Sales Online Sales Distributors/Wholesalers By Industry Automotive Mechanical Electronics & Instruments Aerospace & Defense Footwear & Sports Healthcare Others By Country Malaysia Indonesia Myanmar Philippines Thailand Singapore Vietnam Rest of Southeast Asia Need Strategic Clarity? Talk to Our Analyst Today: About Astute Analytica Astute Analytica is a global market research and advisory firm providing data-driven insights across industries such as technology, healthcare, chemicals, semiconductors, FMCG, and more. We publish multiple reports daily, equipping businesses with the intelligence they need to navigate market trends, emerging opportunities, competitive landscapes, and technological advancements. With a team of experienced business analysts, economists, and industry experts, we deliver accurate, in-depth, and actionable research tailored to meet the strategic needs of our clients. At Astute Analytica, our clients come first, and we are committed to delivering cost-effective, high-value research solutions that drive success in an evolving marketplace. Contact Us:Astute AnalyticaPhone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)For Sales Enquiries: sales@ Follow us on: LinkedIn | Twitter | YouTube CONTACT: Contact Us: Astute Analytica Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World) For Sales Enquiries: sales@ Website: in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
36 minutes ago
- Yahoo
Stock market today: S&P 500, Nasdaq rise as earnings flood in and focus turns to the Fed
US stocks moved higher on Tuesday, eyeing a bid for more records as investors combed through a fresh rush of corporate earnings and waited for key economic data in a big week on Wall Street. The S&P 500 (^GSPC) rose 0.2% on the heels of narrowly notching a sixth all-time closing high in a row, while the tech-heavy Nasdaq Composite (^IXIC) led the way higher with a 0.4% gain. The Dow Jones Industrial Average (^DJI) was roughly flat. The mood is modestly upbeat as a blockbuster week for markets gets into full swing, as the Federal Reserve kicks off its two-day policy meeting on Tuesday. Meanwhile, the JOLTS job openings update for June due later ushers in a string of labor data crucial to interest-rate bets, culminating in Friday's nonfarm payrolls report. For now, earnings take center stage after Boeing's (BA) quarterly results topped expectations, lifting shares in the world's largest planemaker. But second quarter reports from Spotify (SPOT), Merck (MRK), and UnitedHealth (UNH) disappointed Wall Street. Read more: Full earnings coverage in our live blog After the bell, Starbucks (SBUX) earnings will be watched for signs of turnaround progress. Tuesday's earnings help set the tone for this week's highly anticipated reports from Apple (AAPL), Amazon (AMZN), Microsoft (MSFT), and Meta (META). Also looming large is President Trump's deadline Friday for trading partners to strike deals or face blanket tariff rates. Hopes for an extension to the US-China trade truce are buoying the likes of AI chipmaker Nvidia's (NVDA) stock. Read more: The latest on Trump's tariffs Commerce Department data out Tuesday showed the US goods trade deficit hit a 2-year low in June, as imports tumbled and businesses looked to get ahead of tariffs. Also on the economic docket are the Conference Board's July reading on consumer confidence and a S&P CoreLogic print on home prices. Consumer confidence ticks higher in July but job concerns persist Consumer confidence saw an uptick in July with many Americans adjusting their expectations following the rebound from the tariff lows triggered by President Trump's Liberation Day announcements. However, confidence still lags behind the elevated levels observed last year, according to new data released Tuesday morning. The Conference Board's Consumer Confidence Index for July rose to 97.2, surpassing both June's revised figure of 95.2 and the 96.0 reading anticipated by economists. "In July, pessimism about the future receded somewhat, leading to a slight improvement in overall confidence," Stephanie Guichard, senior economist of global indicators at The Conference Board, said in the release. The "Present Situation Index," which measures consumers' assessment of current business and labor market conditions, fell 1.5 points to 131.5 in July. The "Expectations Index," which tracks consumers' short-term outlook for income, business, and labor market conditions, rose to 74.4 in February from 69.9 last month. Historically, a reading below 80 in that category signals a recession in the coming year. Notably, Americans' appraisal of current job availability weakened for the seventh consecutive month, reaching its lowest point since March 2021. In July, 18.9% of consumers reported that jobs were hard to get, up from 14.5% in January. According to Guichard, consumers' write-in responses also highlighted that tariffs remained a significant concern, with many associating them with fears of rising prices. References to high prices and inflation also increased in July, even as consumers' average 12-month inflation expectations eased slightly to 5.8%, down from 5.9% in June and a peak of 7% in April. Job openings slide in June, as hiring rate hits 7-month low Job openings declined in June while hiring also decreased, according to government data released Tuesday. The report comes as investors closely watch for any signs of slowing in the labor market amid a debate over when the Federal Reserve could cut interest rates again. New data from the Bureau of Labor Statistics showed 7.44 million jobs open at the end of June, a decrease from the 7.71 million seen the month prior. May's report had showed the highest number of job openings since November 2024. The Job Openings and Labor Turnover Survey (JOLTS) also showed that 5.2 million hires were made during the month, down from the 5.47 million made during May. The hiring rate ticked lower to 3.3% from the 3.4% seen the month prior and stood at its lowest level since November 2024. In one sign that workers remain cautious about labor market conditions, the quits rate, a sign of confidence among workers, hovered at 2%. Both the hiring and quits rates are hovering near decade lows, reflecting what economists have described as a labor market in "stasis." Royal Caribbean lifts annual profit forecast on steady cruise demand Royal Caribbean's (RCL) stock fell 8% on Tuesday after the cruise line forecast its current-quarter profit below estimates. The company raised its annual forecast and is banking on resilient demand for its luxury destinations. Reuters reports: Read more here. P&G dips as it warns of $1 billion tariff hit Procter & Gamble (PG) stock dipped about 1%, reversing a slight premarket gain, as the company took a cautious approach with its financial outlook while it navigates uncertain consumer sentiment and Trump's tariffs. Yahoo Finance's Brian Sozzi reports: Read the full story here. Tech leads stocks higher at the open The tech-heavy Nasdaq Composite (^IXIC) led US stocks higher at the open on Tuesday morning with a 0.5% gain. Meanwhile, the S&P 500 (^GSPC) rose 0.2% on the heels of notching a sixth all-time closing high in a row on Monday. The Dow Jones Industrial Average (^DJI) opened roughly flat. Investors are digesting a wave of earnings reports and US trade data showing a sharp narrowing in the deficit (as tariffs loom). Meanwhile, they are looking ahead to the JOLTS job openings update for June at 10 a.m. ET. for labor market insight. Major drugmakers mixed amid earnings Of the notable drugmakers reporting earnings Tuesday, AstraZeneca rose almost 2% and Merck fell nearly 4% before the market open. British drugmaker AstraZeneca reported second quarter revenue ahead of expectations Tuesday, with its cancer drugs helping fuel sales for the period. Meanwhile, fellow pharma giant Merck reported earnings below Wall Street's projections, according to Bloomberg consensus data, and revenue from its HPV vaccine Gardasil was also less than expected amid continued headwinds in China. Investors are also bracing for patents for its drug Keytruda (which accounted for roughly half of its second quarter revenue) to expire in 2028. Also on Tuesday, Danish drugmaker Novo Nordisk (NVO) plummeted roughly 20%. The firm cut its 2025 revenue and profit outlook, pointing to lower than expected sales growth of its obesity drug Wegovy in the US, ahead of its second quarter earnings results slated for Aug. 6. Trump's DOJ puts companies on notice: Don't evade tariffs The Justice Department is putting American companies on notice that they could be prosecuted if they chose to evade President Trump's tariffs, even as the legality of the president's "Liberation Day" duties remain unsettled in US courts. Yahoo Finance's Alexis Keenan reports: Read more here. Nvidia leads Mag 7 higher on sign of 'enormous pent-up demand' from China Nvidia (NVDA) led the Big Tech "Magnificent Seven" stocks higher on Tuesday before the market open, climbing 1.4%. The gain came after Reuters reported that the AI chipmaker had ordered 300,000 H20 chips from its contract manufacturer TSMC. "This supports our theory that there is enormous pent-up demand for NVDA chips from China right now," Hedgeye Risk Management analyst Felix Wang wrote in a note to clients. Meanwhile, Microsoft (MSFT), Meta (META), and Amazon (AMZN) rose fractionally ahead of their quarterly earnings reports later this week. Apple (AAPL), Google (GOOG), and Tesla (TSLA) traded down less than 1%. Good morning. Here's what's happening today. Economic data: S&P CoreLogic 20-city home price index (May); Conference Board consumer confidence, July; Job Openings and Labor Turnover Survey (June); Dallas Fed services activity (July) Earnings: Boeing (BA), Booking Holdings (BKNG), Caesars (CZR), Cheesecake Factory (CAKE), Merck (MRK), PayPal (PYPL), Procter & Gamble (PG), Spotify (SPOT), Starbucks (SBUX), SoFi (SOFI), UnitedHealth Group (UNH), UPS (UPS), Visa (V) Here are some of the biggest stories you may have missed overnight and early this morning: The market is finally getting what it wants 35 charts explain markets and the economy right now UnitedHealth stock falls after reporting mixed Q2 earnings Sarepta stock soars as FDA reverses course on gene therapy pause Spotify stock slides after Q2 earnings and revenue miss Trump's DOJ puts companies on notice on tariffs US, EU rush to clinch final details and lock in trade deal Apple to Shutter a Retail Store in China for the First Time Ever Stellantis faces $1.7B hit from US tariffs this year Trending tickers: UPS, Whilepool and Royal Caribbean Here are some top stocks trending on Yahoo Finance in premarket trading: UPS (UPS) stock fell over 2% before the bell on Tuesday after reporting a drop in second-quarter profit and revenue, as demand took a hit from new "de minimis" tariffs on low-value Chinese shipments and mounting risks from President Donald Trump's trade policies. Whirlpool (WHR) stock fell premarket on Tuesday. after the appliance maker slashed its earnings outlook the day prior. Royal Caribbean (RCL) stock rose 4% before the bell after raising its annual profit forecast on Tuesday, banking on resilient demand for the cruise operator's high-end private island destinations and premium sailings. The market is finally getting what it wants Wall Street's busiest week of the summer is turning out to be an inflection point. Yahoo Finance's Hamza Shaban explains why in today's Morning Brief: Read more here. Spotify stock sinks after Q2 earnings miss Spotify (SPOT) shares fell as much as 10% in early premarket trading Tuesday after the company missed second quarter earnings and revenue expectations. The results follow a remarkable 120% rally over the past year, as the stock rebounded from 2022 lows on the back of price hikes, cost cuts, and investor enthusiasm for AI and advertising. Spotify hit a record high of $738.45 earlier this month, but shares slid to around $635 immediately following the results. Spotify reported second quarter revenue of €4.19 billion ($4.86 billion), missing analyst expectations of €4.27 billion, though up from €3.81 billion in the same period last year. The company posted an adjusted loss of €0.42 ($0.49) per share, sharply missing forecasts for a profit of €1.97 and down from earnings of €1.33 in Q2 2024. "Outsized currency movements during the quarter impacted reported revenue by €104 million vs. guidance," the company said in the earnings release. Operating income also fell short of expectations in the quarter, though subscriber metrics for both premium and ad-supported tiers came in ahead of estimates. Gross margins of 31.5% came in as expected. Spotify's massive rally heading into the earnings report was fueled by a sweeping business overhaul, including layoffs, leadership changes, and a pullback from costly podcast exclusivity. After spending $1 billion to build out its podcast business, the company has since scaled back and narrowed its focus. Still, it remains committed to the medium, paying over $100 million to creators in Q1 alone, including high-profile names like Joe Rogan and Alex Cooper. Read more here. UnitedHealth stock slips after mixed Q2 results Shares of UnitedHealth Group (UNH) fell nearly 3% after its quarterly results before the bell painted a mixed picture. Yahoo Finance's Anjalee Khemlani reports: Read more here. Sarepta stock rockets higher after FDA greenlight Shares in drugmaker Sarepta (SRPT) rocketed up over 30% in premarket after the embattled company got the FDA's go-ahead to resume shipments of its Elevdis gene therapy. The greenlight comes after Sarepta put a voluntary pause on shipments for some patients while the US regulator reviewed its safety following deaths. The FDA on Monday recommended that the compa lift that halt. Sarepta's stock is poised to build on a 16% gain on Monday, continuing a recent volatile spell triggered by changing fortunes for its best-selling product. AP reports: Read more here. Nvidia orders 300,000 H20 chips from TSMC to satiate Chinese demand Reuters reports: Nvidia placed orders for 300,000 H20 chipsets with contract manufacturer TSMC last week, two sources said, with one of them adding that strong Chinese demand had led the U.S. firm to change its mind about just relying on its existing stockpile. Read more here. Oil maintains gains with tariffs and OPEC+ supply in sight Oil maintained gains following Trump putting pressure on Russia over the war in Ukraine with economic sanctions against Putin's government on the table. Bloomberg reports: Read more here. Consumer confidence ticks higher in July but job concerns persist Consumer confidence saw an uptick in July with many Americans adjusting their expectations following the rebound from the tariff lows triggered by President Trump's Liberation Day announcements. However, confidence still lags behind the elevated levels observed last year, according to new data released Tuesday morning. The Conference Board's Consumer Confidence Index for July rose to 97.2, surpassing both June's revised figure of 95.2 and the 96.0 reading anticipated by economists. "In July, pessimism about the future receded somewhat, leading to a slight improvement in overall confidence," Stephanie Guichard, senior economist of global indicators at The Conference Board, said in the release. The "Present Situation Index," which measures consumers' assessment of current business and labor market conditions, fell 1.5 points to 131.5 in July. The "Expectations Index," which tracks consumers' short-term outlook for income, business, and labor market conditions, rose to 74.4 in February from 69.9 last month. Historically, a reading below 80 in that category signals a recession in the coming year. Notably, Americans' appraisal of current job availability weakened for the seventh consecutive month, reaching its lowest point since March 2021. In July, 18.9% of consumers reported that jobs were hard to get, up from 14.5% in January. According to Guichard, consumers' write-in responses also highlighted that tariffs remained a significant concern, with many associating them with fears of rising prices. References to high prices and inflation also increased in July, even as consumers' average 12-month inflation expectations eased slightly to 5.8%, down from 5.9% in June and a peak of 7% in April. Consumer confidence saw an uptick in July with many Americans adjusting their expectations following the rebound from the tariff lows triggered by President Trump's Liberation Day announcements. However, confidence still lags behind the elevated levels observed last year, according to new data released Tuesday morning. The Conference Board's Consumer Confidence Index for July rose to 97.2, surpassing both June's revised figure of 95.2 and the 96.0 reading anticipated by economists. "In July, pessimism about the future receded somewhat, leading to a slight improvement in overall confidence," Stephanie Guichard, senior economist of global indicators at The Conference Board, said in the release. The "Present Situation Index," which measures consumers' assessment of current business and labor market conditions, fell 1.5 points to 131.5 in July. The "Expectations Index," which tracks consumers' short-term outlook for income, business, and labor market conditions, rose to 74.4 in February from 69.9 last month. Historically, a reading below 80 in that category signals a recession in the coming year. Notably, Americans' appraisal of current job availability weakened for the seventh consecutive month, reaching its lowest point since March 2021. In July, 18.9% of consumers reported that jobs were hard to get, up from 14.5% in January. According to Guichard, consumers' write-in responses also highlighted that tariffs remained a significant concern, with many associating them with fears of rising prices. References to high prices and inflation also increased in July, even as consumers' average 12-month inflation expectations eased slightly to 5.8%, down from 5.9% in June and a peak of 7% in April. Job openings slide in June, as hiring rate hits 7-month low Job openings declined in June while hiring also decreased, according to government data released Tuesday. The report comes as investors closely watch for any signs of slowing in the labor market amid a debate over when the Federal Reserve could cut interest rates again. New data from the Bureau of Labor Statistics showed 7.44 million jobs open at the end of June, a decrease from the 7.71 million seen the month prior. May's report had showed the highest number of job openings since November 2024. The Job Openings and Labor Turnover Survey (JOLTS) also showed that 5.2 million hires were made during the month, down from the 5.47 million made during May. The hiring rate ticked lower to 3.3% from the 3.4% seen the month prior and stood at its lowest level since November 2024. In one sign that workers remain cautious about labor market conditions, the quits rate, a sign of confidence among workers, hovered at 2%. Both the hiring and quits rates are hovering near decade lows, reflecting what economists have described as a labor market in "stasis." Job openings declined in June while hiring also decreased, according to government data released Tuesday. The report comes as investors closely watch for any signs of slowing in the labor market amid a debate over when the Federal Reserve could cut interest rates again. New data from the Bureau of Labor Statistics showed 7.44 million jobs open at the end of June, a decrease from the 7.71 million seen the month prior. May's report had showed the highest number of job openings since November 2024. The Job Openings and Labor Turnover Survey (JOLTS) also showed that 5.2 million hires were made during the month, down from the 5.47 million made during May. The hiring rate ticked lower to 3.3% from the 3.4% seen the month prior and stood at its lowest level since November 2024. In one sign that workers remain cautious about labor market conditions, the quits rate, a sign of confidence among workers, hovered at 2%. Both the hiring and quits rates are hovering near decade lows, reflecting what economists have described as a labor market in "stasis." Royal Caribbean lifts annual profit forecast on steady cruise demand Royal Caribbean's (RCL) stock fell 8% on Tuesday after the cruise line forecast its current-quarter profit below estimates. The company raised its annual forecast and is banking on resilient demand for its luxury destinations. Reuters reports: Read more here. Royal Caribbean's (RCL) stock fell 8% on Tuesday after the cruise line forecast its current-quarter profit below estimates. The company raised its annual forecast and is banking on resilient demand for its luxury destinations. Reuters reports: Read more here. P&G dips as it warns of $1 billion tariff hit Procter & Gamble (PG) stock dipped about 1%, reversing a slight premarket gain, as the company took a cautious approach with its financial outlook while it navigates uncertain consumer sentiment and Trump's tariffs. Yahoo Finance's Brian Sozzi reports: Read the full story here. Procter & Gamble (PG) stock dipped about 1%, reversing a slight premarket gain, as the company took a cautious approach with its financial outlook while it navigates uncertain consumer sentiment and Trump's tariffs. Yahoo Finance's Brian Sozzi reports: Read the full story here. Tech leads stocks higher at the open The tech-heavy Nasdaq Composite (^IXIC) led US stocks higher at the open on Tuesday morning with a 0.5% gain. Meanwhile, the S&P 500 (^GSPC) rose 0.2% on the heels of notching a sixth all-time closing high in a row on Monday. The Dow Jones Industrial Average (^DJI) opened roughly flat. Investors are digesting a wave of earnings reports and US trade data showing a sharp narrowing in the deficit (as tariffs loom). Meanwhile, they are looking ahead to the JOLTS job openings update for June at 10 a.m. ET. for labor market insight. The tech-heavy Nasdaq Composite (^IXIC) led US stocks higher at the open on Tuesday morning with a 0.5% gain. Meanwhile, the S&P 500 (^GSPC) rose 0.2% on the heels of notching a sixth all-time closing high in a row on Monday. The Dow Jones Industrial Average (^DJI) opened roughly flat. Investors are digesting a wave of earnings reports and US trade data showing a sharp narrowing in the deficit (as tariffs loom). Meanwhile, they are looking ahead to the JOLTS job openings update for June at 10 a.m. ET. for labor market insight. Major drugmakers mixed amid earnings Of the notable drugmakers reporting earnings Tuesday, AstraZeneca rose almost 2% and Merck fell nearly 4% before the market open. British drugmaker AstraZeneca reported second quarter revenue ahead of expectations Tuesday, with its cancer drugs helping fuel sales for the period. Meanwhile, fellow pharma giant Merck reported earnings below Wall Street's projections, according to Bloomberg consensus data, and revenue from its HPV vaccine Gardasil was also less than expected amid continued headwinds in China. Investors are also bracing for patents for its drug Keytruda (which accounted for roughly half of its second quarter revenue) to expire in 2028. Also on Tuesday, Danish drugmaker Novo Nordisk (NVO) plummeted roughly 20%. The firm cut its 2025 revenue and profit outlook, pointing to lower than expected sales growth of its obesity drug Wegovy in the US, ahead of its second quarter earnings results slated for Aug. 6. Of the notable drugmakers reporting earnings Tuesday, AstraZeneca rose almost 2% and Merck fell nearly 4% before the market open. British drugmaker AstraZeneca reported second quarter revenue ahead of expectations Tuesday, with its cancer drugs helping fuel sales for the period. Meanwhile, fellow pharma giant Merck reported earnings below Wall Street's projections, according to Bloomberg consensus data, and revenue from its HPV vaccine Gardasil was also less than expected amid continued headwinds in China. Investors are also bracing for patents for its drug Keytruda (which accounted for roughly half of its second quarter revenue) to expire in 2028. Also on Tuesday, Danish drugmaker Novo Nordisk (NVO) plummeted roughly 20%. The firm cut its 2025 revenue and profit outlook, pointing to lower than expected sales growth of its obesity drug Wegovy in the US, ahead of its second quarter earnings results slated for Aug. 6. Trump's DOJ puts companies on notice: Don't evade tariffs The Justice Department is putting American companies on notice that they could be prosecuted if they chose to evade President Trump's tariffs, even as the legality of the president's "Liberation Day" duties remain unsettled in US courts. Yahoo Finance's Alexis Keenan reports: Read more here. The Justice Department is putting American companies on notice that they could be prosecuted if they chose to evade President Trump's tariffs, even as the legality of the president's "Liberation Day" duties remain unsettled in US courts. Yahoo Finance's Alexis Keenan reports: Read more here. Nvidia leads Mag 7 higher on sign of 'enormous pent-up demand' from China Nvidia (NVDA) led the Big Tech "Magnificent Seven" stocks higher on Tuesday before the market open, climbing 1.4%. The gain came after Reuters reported that the AI chipmaker had ordered 300,000 H20 chips from its contract manufacturer TSMC. "This supports our theory that there is enormous pent-up demand for NVDA chips from China right now," Hedgeye Risk Management analyst Felix Wang wrote in a note to clients. Meanwhile, Microsoft (MSFT), Meta (META), and Amazon (AMZN) rose fractionally ahead of their quarterly earnings reports later this week. Apple (AAPL), Google (GOOG), and Tesla (TSLA) traded down less than 1%. Nvidia (NVDA) led the Big Tech "Magnificent Seven" stocks higher on Tuesday before the market open, climbing 1.4%. The gain came after Reuters reported that the AI chipmaker had ordered 300,000 H20 chips from its contract manufacturer TSMC. "This supports our theory that there is enormous pent-up demand for NVDA chips from China right now," Hedgeye Risk Management analyst Felix Wang wrote in a note to clients. Meanwhile, Microsoft (MSFT), Meta (META), and Amazon (AMZN) rose fractionally ahead of their quarterly earnings reports later this week. Apple (AAPL), Google (GOOG), and Tesla (TSLA) traded down less than 1%. Good morning. Here's what's happening today. Economic data: S&P CoreLogic 20-city home price index (May); Conference Board consumer confidence, July; Job Openings and Labor Turnover Survey (June); Dallas Fed services activity (July) Earnings: Boeing (BA), Booking Holdings (BKNG), Caesars (CZR), Cheesecake Factory (CAKE), Merck (MRK), PayPal (PYPL), Procter & Gamble (PG), Spotify (SPOT), Starbucks (SBUX), SoFi (SOFI), UnitedHealth Group (UNH), UPS (UPS), Visa (V) Here are some of the biggest stories you may have missed overnight and early this morning: The market is finally getting what it wants 35 charts explain markets and the economy right now UnitedHealth stock falls after reporting mixed Q2 earnings Sarepta stock soars as FDA reverses course on gene therapy pause Spotify stock slides after Q2 earnings and revenue miss Trump's DOJ puts companies on notice on tariffs US, EU rush to clinch final details and lock in trade deal Apple to Shutter a Retail Store in China for the First Time Ever Stellantis faces $1.7B hit from US tariffs this year Economic data: S&P CoreLogic 20-city home price index (May); Conference Board consumer confidence, July; Job Openings and Labor Turnover Survey (June); Dallas Fed services activity (July) Earnings: Boeing (BA), Booking Holdings (BKNG), Caesars (CZR), Cheesecake Factory (CAKE), Merck (MRK), PayPal (PYPL), Procter & Gamble (PG), Spotify (SPOT), Starbucks (SBUX), SoFi (SOFI), UnitedHealth Group (UNH), UPS (UPS), Visa (V) Here are some of the biggest stories you may have missed overnight and early this morning: The market is finally getting what it wants 35 charts explain markets and the economy right now UnitedHealth stock falls after reporting mixed Q2 earnings Sarepta stock soars as FDA reverses course on gene therapy pause Spotify stock slides after Q2 earnings and revenue miss Trump's DOJ puts companies on notice on tariffs US, EU rush to clinch final details and lock in trade deal Apple to Shutter a Retail Store in China for the First Time Ever Stellantis faces $1.7B hit from US tariffs this year Trending tickers: UPS, Whilepool and Royal Caribbean Here are some top stocks trending on Yahoo Finance in premarket trading: UPS (UPS) stock fell over 2% before the bell on Tuesday after reporting a drop in second-quarter profit and revenue, as demand took a hit from new "de minimis" tariffs on low-value Chinese shipments and mounting risks from President Donald Trump's trade policies. Whirlpool (WHR) stock fell premarket on Tuesday. after the appliance maker slashed its earnings outlook the day prior. Royal Caribbean (RCL) stock rose 4% before the bell after raising its annual profit forecast on Tuesday, banking on resilient demand for the cruise operator's high-end private island destinations and premium sailings. Here are some top stocks trending on Yahoo Finance in premarket trading: UPS (UPS) stock fell over 2% before the bell on Tuesday after reporting a drop in second-quarter profit and revenue, as demand took a hit from new "de minimis" tariffs on low-value Chinese shipments and mounting risks from President Donald Trump's trade policies. Whirlpool (WHR) stock fell premarket on Tuesday. after the appliance maker slashed its earnings outlook the day prior. Royal Caribbean (RCL) stock rose 4% before the bell after raising its annual profit forecast on Tuesday, banking on resilient demand for the cruise operator's high-end private island destinations and premium sailings. The market is finally getting what it wants Wall Street's busiest week of the summer is turning out to be an inflection point. Yahoo Finance's Hamza Shaban explains why in today's Morning Brief: Read more here. Wall Street's busiest week of the summer is turning out to be an inflection point. Yahoo Finance's Hamza Shaban explains why in today's Morning Brief: Read more here. Spotify stock sinks after Q2 earnings miss Spotify (SPOT) shares fell as much as 10% in early premarket trading Tuesday after the company missed second quarter earnings and revenue expectations. The results follow a remarkable 120% rally over the past year, as the stock rebounded from 2022 lows on the back of price hikes, cost cuts, and investor enthusiasm for AI and advertising. Spotify hit a record high of $738.45 earlier this month, but shares slid to around $635 immediately following the results. Spotify reported second quarter revenue of €4.19 billion ($4.86 billion), missing analyst expectations of €4.27 billion, though up from €3.81 billion in the same period last year. The company posted an adjusted loss of €0.42 ($0.49) per share, sharply missing forecasts for a profit of €1.97 and down from earnings of €1.33 in Q2 2024. "Outsized currency movements during the quarter impacted reported revenue by €104 million vs. guidance," the company said in the earnings release. Operating income also fell short of expectations in the quarter, though subscriber metrics for both premium and ad-supported tiers came in ahead of estimates. Gross margins of 31.5% came in as expected. Spotify's massive rally heading into the earnings report was fueled by a sweeping business overhaul, including layoffs, leadership changes, and a pullback from costly podcast exclusivity. After spending $1 billion to build out its podcast business, the company has since scaled back and narrowed its focus. Still, it remains committed to the medium, paying over $100 million to creators in Q1 alone, including high-profile names like Joe Rogan and Alex Cooper. Read more here. Spotify (SPOT) shares fell as much as 10% in early premarket trading Tuesday after the company missed second quarter earnings and revenue expectations. The results follow a remarkable 120% rally over the past year, as the stock rebounded from 2022 lows on the back of price hikes, cost cuts, and investor enthusiasm for AI and advertising. Spotify hit a record high of $738.45 earlier this month, but shares slid to around $635 immediately following the results. Spotify reported second quarter revenue of €4.19 billion ($4.86 billion), missing analyst expectations of €4.27 billion, though up from €3.81 billion in the same period last year. The company posted an adjusted loss of €0.42 ($0.49) per share, sharply missing forecasts for a profit of €1.97 and down from earnings of €1.33 in Q2 2024. "Outsized currency movements during the quarter impacted reported revenue by €104 million vs. guidance," the company said in the earnings release. Operating income also fell short of expectations in the quarter, though subscriber metrics for both premium and ad-supported tiers came in ahead of estimates. Gross margins of 31.5% came in as expected. Spotify's massive rally heading into the earnings report was fueled by a sweeping business overhaul, including layoffs, leadership changes, and a pullback from costly podcast exclusivity. After spending $1 billion to build out its podcast business, the company has since scaled back and narrowed its focus. Still, it remains committed to the medium, paying over $100 million to creators in Q1 alone, including high-profile names like Joe Rogan and Alex Cooper. Read more here. UnitedHealth stock slips after mixed Q2 results Shares of UnitedHealth Group (UNH) fell nearly 3% after its quarterly results before the bell painted a mixed picture. Yahoo Finance's Anjalee Khemlani reports: Read more here. Shares of UnitedHealth Group (UNH) fell nearly 3% after its quarterly results before the bell painted a mixed picture. Yahoo Finance's Anjalee Khemlani reports: Read more here. Sarepta stock rockets higher after FDA greenlight Shares in drugmaker Sarepta (SRPT) rocketed up over 30% in premarket after the embattled company got the FDA's go-ahead to resume shipments of its Elevdis gene therapy. The greenlight comes after Sarepta put a voluntary pause on shipments for some patients while the US regulator reviewed its safety following deaths. The FDA on Monday recommended that the compa lift that halt. Sarepta's stock is poised to build on a 16% gain on Monday, continuing a recent volatile spell triggered by changing fortunes for its best-selling product. AP reports: Read more here. Shares in drugmaker Sarepta (SRPT) rocketed up over 30% in premarket after the embattled company got the FDA's go-ahead to resume shipments of its Elevdis gene therapy. The greenlight comes after Sarepta put a voluntary pause on shipments for some patients while the US regulator reviewed its safety following deaths. The FDA on Monday recommended that the compa lift that halt. Sarepta's stock is poised to build on a 16% gain on Monday, continuing a recent volatile spell triggered by changing fortunes for its best-selling product. AP reports: Read more here. Nvidia orders 300,000 H20 chips from TSMC to satiate Chinese demand Reuters reports: Nvidia placed orders for 300,000 H20 chipsets with contract manufacturer TSMC last week, two sources said, with one of them adding that strong Chinese demand had led the U.S. firm to change its mind about just relying on its existing stockpile. Read more here. Reuters reports: Nvidia placed orders for 300,000 H20 chipsets with contract manufacturer TSMC last week, two sources said, with one of them adding that strong Chinese demand had led the U.S. firm to change its mind about just relying on its existing stockpile. Read more here. Oil maintains gains with tariffs and OPEC+ supply in sight Oil maintained gains following Trump putting pressure on Russia over the war in Ukraine with economic sanctions against Putin's government on the table. Bloomberg reports: Read more here. Oil maintained gains following Trump putting pressure on Russia over the war in Ukraine with economic sanctions against Putin's government on the table. Bloomberg reports: Read more here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data